Liquid AI

Liquid AI is an MIT spin-off that develops Liquid Foundation Models (LFMs), a novel class of AI architectures based on dynamical systems and signal processing. Unlike traditional transformer-based models, LFMs are highly efficient, adaptable, and capable of running on-premise or on-device with a significantly reduced memory footprint. In the life sciences sector, Liquid AI has established a major strategic partnership with Insilico Medicine to deploy specialized foundation models like LFM2-2.6B-MMAI for end-to-end drug discovery. These models enable pharmaceutical companies to perform complex tasks such as property prediction, ADMET screening, and molecular optimization within private, secure infrastructures. The company's technology is inspired by the neural efficiency of biological organisms, specifically the C. elegans nematode, and aims to provide "pharmaceutical superintelligence" at the edge. Headquartered in Brookline, Massachusetts, the company is backed by major investors including AMD Ventures and Samsung.